E-course: New treatment options in mCRPC

Join us in this new e-course "New treatment options in mCRPC", which is organised in collaboration with the EAU Section of Oncological Urology (ESOU). The panel of experts will provide you with key takeaways, the latest updates, and helpful insights on metastatic castration-resistant prostate cancer (mCRPC).

Published Tue, 6 Jun 2023
E CourseProstate CancerM CRPCNew TreatmentProstate Cancer
Organiser European School of Urology (ESU)
CME Approved
Duration Approx. 60 minutes

They will identify and examine the current status of CRPC management, as well as dive into the challenges encountered in clinical practice. In addition, you will gain insights on the criteria and description of what make a patient the right candidate for personalised medicine and molecular testing.


  • Prof. N.W. Clarke (UK)
  • Prof. S. Joniau (BE)
  • Dr. F.S. Schlürmann (FR)


This activity is supported by an educational grant from a Pharmaceutical company, with no involvement in the programme or speaker selection.

Contact our organiser

European School of Urology (ESU)

Email:  educationonline@uroweb.org